Bringing Stick-to-itiveness to Regenerative Medicine

Luis Alvarez, CEO of Theradaptive, discusses his company’s platform technology to produce recombinant proteins that bind to the surface of implants, devices, and injectable carriers to allow for precision delivery anywhere in the body; the broad application for the technology; and how the roots of the company go back to a need he saw during his service in the Iraq war.